Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lipella Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2025 was -1367.4%. For fiscal 2024 it was -935.2%, against -1027.3% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -935.2% | +92.1 |
| FY2023 | Dec 31, 2023 | -1027.3% | +383.3 |
| FY2022 | Dec 31, 2022 | -1410.6% | −691.3 |
| FY2021 | Dec 31, 2021 | -719.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -1530.6% | −843.0 |
| Q1 FY2025 | Mar 31, 2025 | -1009.8% | −192.8 |
| Q4 FY2024 | Dec 31, 2024 | -830.1% | −260.1 |
| Q3 FY2024 | Sep 30, 2024 | -1797.3% | −525.2 |
| Q2 FY2024 | Jun 30, 2024 | -687.6% | +754.8 |
| Q1 FY2024 | Mar 31, 2024 | -817.0% | +87.6 |
| Q4 FY2023 | Dec 31, 2023 | -570.1% | −329.1 |
| Q3 FY2023 | Sep 30, 2023 | -1272.0% | +954.1 |
| Q2 FY2023 | Jun 30, 2023 | -1442.4% | – |
| Q1 FY2023 | Mar 31, 2023 | -904.6% | – |
| Q4 FY2022 | Dec 31, 2022 | -241.0% | – |
| Q1 FY2022 | Mar 31, 2022 | -2226.2% | – |
See a number that looks wrong?